Eupraxia Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $15.1M | $12.5M |
| FY2022 | — | $7.8M | $18.3M |
| FY2023 | — | $2.2M | $19.3M |
| FY2024 | — | $33.4M | $33.1M |
| FY2025 | — | $82.0M | $80.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $15.1M | $12.5M |
| FY2022 | — | $7.8M | $18.3M |
| FY2023 | — | $2.2M | $19.3M |
| FY2024 | — | $33.4M | $33.1M |
| FY2025 | — | $82.0M | $80.6M |